Cargando…
Additive Toxicity of β-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer’s Disease
BACKGROUND: β-amyloid is regarded as a significant factor in Alzheimer’s disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. One cl...
Autores principales: | Garcia-Ratés, Sara, Lewis, Matthew, Worrall, Rosemary, Greenfield, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563650/ https://www.ncbi.nlm.nih.gov/pubmed/23390503 http://dx.doi.org/10.1371/journal.pone.0054864 |
Ejemplares similares
-
Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease
por: Greenfield, Susan Adele, et al.
Publicado: (2022) -
A Novel Bioactive Peptide, T14, Selectively Activates mTORC1 Signalling: Therapeutic Implications for Neurodegeneration and Other Rapamycin-Sensitive Applications
por: Ranglani, Sanskar, et al.
Publicado: (2023) -
Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2020) -
Amyloid Peptide Toxicity in an Animal Model of Alzheimer Disease
por: Gross, Liza
Publicado: (2007) -
Calcium Ions Promote Formation of Amyloid β-Peptide (1–40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease
por: Itkin, Anna, et al.
Publicado: (2011)